Adaptive Biotechnologies Salaries & Compensation
Tech
Adaptive Biotechnologies develops an immune medicine platform for diagnosing and treating diseases, including cancer, autoimmune conditions, and infectious diseases. Its products include immunoSEQ, T-Detect COVID, clonoSEQ, and immunoSEQ T-MAP COVID. The company collaborates with Genentech and Microsoft to develop therapies and diagnostic tests. Adaptive Biotechnologies was founded in 2009 and is headquartered in Seattle, Washington.
Headquarters:Seattle, United States
Founded:2009
Employees:201-1,000
Type:public
Est. Revenue:$100M-$250M
6
Salary entries
$118K
Avg total comp
$130K
Median total comp
USD
Currency
Stats shown in USD (converted). Select a country for accurate local figures.
Headquarters